Becton, Dickinson [BDX] vs Hologic [HOLX] Detailed Stock Comparison

Becton, Dickinson

NYSE
Loading...

Hologic

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Becton, Dickinson wins in 10 metrics, Hologic wins in 9 metrics, with 0 ties. Becton, Dickinson appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricBecton, DickinsonHologicBetter
P/E Ratio (TTM)33.7927.86Hologic
Price-to-Book Ratio2.153.08Becton, Dickinson
Debt-to-Equity Ratio75.9352.09Hologic
PEG Ratio1.775.78Becton, Dickinson
EV/EBITDA12.3912.47Becton, Dickinson
Profit Margin (TTM)7.41%13.79%Hologic
Operating Margin (TTM)17.81%25.48%Hologic
EBITDA Margin (TTM)17.81%25.48%Hologic
Return on Equity6.18%11.38%Hologic
Return on Assets (TTM)3.96%6.69%Hologic
Free Cash Flow (TTM)$3.07B$1.15BBecton, Dickinson
Dividend Yield1.80%N/AN/A
1-Year Return-19.57%-15.37%Hologic
Price-to-Sales Ratio (TTM)2.563.70Becton, Dickinson
Enterprise Value$73.31B$15.57BBecton, Dickinson
EV/Revenue Ratio3.433.86Becton, Dickinson
Gross Profit Margin (TTM)47.81%56.32%Hologic
Revenue per Share (TTM)$74$18Becton, Dickinson
Earnings per Share (Diluted)$5.65$2.41Becton, Dickinson
Beta (Stock Volatility)0.280.57Becton, Dickinson
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Becton, Dickinson vs Hologic Stock Performance Analysis

Loading Price Chart...

Becton, Dickinson
Hologic
Becton, Dickinson Stock Overview | Hologic Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Becton, Dickinson0.35%6.10%1.83%8.08%-15.38%-15.40%
Hologic1.30%3.22%1.95%4.00%12.14%-5.34%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Becton, Dickinson-19.57%-13.95%-17.24%42.56%162.72%278.88%
Hologic-15.37%6.51%-2.13%82.16%322.59%379.59%

News Based Sentiment: Becton, Dickinson vs Hologic

Becton, Dickinson

News based Sentiment: POSITIVE

Becton Dickinson had a strong month driven by a significant earnings beat, upward guidance revision, and a strategic partnership focused on the growing pharmacy automation market. While insider selling exists, the overall narrative is positive, supported by high institutional ownership and positive analyst coverage.

View Becton, Dickinson News Sentiment Analysis

Hologic

News based Sentiment: NEUTRAL

The month's news for Hologic paints a picture of stability rather than dramatic growth. While the stock outperformed the S&P 500 slightly and analyst estimates are trending upward, the overall sentiment is neutral due to the 'Hold' rating and modest gains. The valuation metrics suggest potential value, but don't indicate a strong buy signal.

View Hologic News Sentiment Analysis

Performance & Financial Health Analysis: Becton, Dickinson vs Hologic

MetricBDXHOLX
Market Information
Market Cap i$55.66B$14.94B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,583,8903,267,260
90 Day Avg. Volume i1,641,0002,018,787
Last Close$191.60$67.91
52 Week Range$163.33 - $251.99$51.90 - $84.39
% from 52W High-23.97%-19.53%
All-Time High$287.32 (Jul 24, 2023)$87.88 (May 01, 2023)
% from All-Time High-33.31%-22.72%
Growth Metrics
Quarterly Revenue Growth0.10%0.01%
Quarterly Earnings Growth0.18%0.00%
Financial Health
Profit Margin (TTM) i0.07%0.14%
Operating Margin (TTM) i0.18%0.25%
Return on Equity (TTM) i0.06%0.11%
Debt to Equity (MRQ) i75.9352.09
Cash & Liquidity
Book Value per Share (MRQ)$88.87$21.79
Cash per Share (MRQ)$2.64$8.47
Operating Cash Flow (TTM) i$3.25B$1.07B
Levered Free Cash Flow (TTM) i$3.37B$760.11M
Dividends
Last 12-Month Dividend Yield i1.80%N/A
Last 12-Month Dividend i$3.03N/A

Valuation & Enterprise Metrics Analysis: Becton, Dickinson vs Hologic

MetricBDXHOLX
Price Ratios
P/E Ratio (TTM) i33.7927.86
Forward P/E i12.1414.23
PEG Ratio i1.775.78
Price to Sales (TTM) i2.563.70
Price to Book (MRQ) i2.153.08
Market Capitalization
Market Capitalization i$55.66B$14.94B
Enterprise Value i$73.31B$15.57B
Enterprise Value Metrics
Enterprise to Revenue i3.433.86
Enterprise to EBITDA i12.3912.47
Risk & Other Metrics
Beta i0.280.57
Book Value per Share (MRQ) i$88.87$21.79

Financial Statements Comparison: Becton, Dickinson vs Hologic

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)BDXHOLX
Revenue/Sales i$5.27B$1.01B
Cost of Goods Sold i$3.02B$628.00M
Gross Profit i$2.26B$377.30M
Research & Development i$302.00M$61.50M
Operating Income (EBIT) i$637.00M$37.90M
EBITDA i$1.21B$121.70M
Pre-Tax Income i$363.00M$-28.50M
Income Tax i$55.00M$-11.10M
Net Income (Profit) i$308.00M$-17.40M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)BDXHOLX
Cash & Equivalents i$667.00M$1.43B
Total Current Assets i$8.67B$3.21B
Total Current Liabilities i$7.69B$989.70M
Long-Term Debt i$17.67B$2.47B
Total Shareholders Equity i$25.24B$4.62B
Retained Earnings i$16.15B$3.03B
Property, Plant & Equipment iN/A$939.80M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)BDXHOLX
Operating Cash Flow i$941.00M$28.40M
Capital Expenditures iN/A$-24.70M
Free Cash Flow i$35.00M$129.20M
Debt Repayment i$-1.00M$-10.20M
Common Stock Repurchase i$0$-200.00M

Short Interest & Institutional Ownership Analysis

MetricBDXHOLX
Shares Short i4.28M3.11M
Short Ratio i2.412.03
Short % of Float i0.02%0.02%
Average Daily Volume (10 Day) i1,583,8903,267,260
Average Daily Volume (90 Day) i1,641,0002,018,787
Shares Outstanding i289.10M231.73M
Float Shares i286.00M220.32M
% Held by Insiders i0.01%0.01%
% Held by Institutions i0.92%1.01%

Dividend Analysis & Yield Comparison: Becton, Dickinson vs Hologic

MetricBDXHOLX
Last 12-Month Dividend i$3.03N/A
Last 12-Month Dividend Yield i1.80%N/A
3-Year Avg Annual Dividend i$3.16N/A
3-Year Avg Dividend Yield i0.40%N/A
3-Year Total Dividends i$9.48N/A
Ex-Dividend DateMar 10, 2025N/A